JOHNS HOPKINS UNIVERSITY for JOHNS HOPKINS UNIVERSITY
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Technical changes to Stark law; Medicare Physician Fee schedule; in vitro toxicology policy; substance abuse research funding; medical device interoperability and meaningful use
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISA LINDAMOOD | — |
Education EDU
Perkins Loan program; Elementary and Secondary Education Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY GROSSI | — |
Medicare/Medicaid MMM
Graduate medical education funding; Children's Health Insurance Program; Recovery audit contractors; Medicaid IMD exclusion; ICD-10; Emergency Psychiatric Demonstration project, S.599.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH ANN FELDER | — |
| MELISA LINDAMOOD | — |
| DAVID PARKER | — |
Budget/Appropriations BUD
FY16 appropriations; AHRQ funding; NIH funding for biomedical research; HRSA TItle VII Reauthorization, HR 2713
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH ANN FELDER | — |
| JEFFREY GROSSI | — |
| MELISA LINDAMOOD | — |
| DAVID PARKER | — |
Pharmacy PHA
Pharmaceutical drug price increases; 340B drug discount program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISA LINDAMOOD | — |
Science/Technology SCI
Biomedical research and innovation, H.R.6 21st Century Cures Act; Intellectual property and tech transfer, H.R. 9 Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH ANN FELDER | — |
| JEFFREY GROSSI | — |
| MELISA LINDAMOOD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.